Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Molecular Omics, 2022
Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients

Michels J., Nazrul M., Adhikari S. et al.

Olink Explore 3072/384CVDInfectious DiseasesPathophysiologyPlasma

Cancers, 2022
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)

Gezelius E., Bendahl P., Gallo W. et al.

Olink Target 96OncologyPatient StratificationPlasma

Diabetes, 2022
Connecting Genomics and Proteomics to Identify Protein Biomarkers for Adult and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study

Ghanbari F., Yazdanpanah N., Yazdanpanah M. et al.

Olink Target 96Metabolic DiseasesPatient StratificationPlasma

Life, 2022
Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze–Thaw Cycles Apart

Bhardwaj M., Schrotz-King P., Brenner H.

Olink Target 96Technical StudiesTechnical EvaluationPlasma

Journal of Internal Medicine, 2022
The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast

Arias de la Rosa I., López‐Montilla M., Román‐Rodríguez C. et al.

Olink Target 96CVDDermatological DiseasesPathophysiologyPatient StratificationPlasma

JACC: Basic to Translational Science, 2022
Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients

Kaye D., Nanayakkara S., Wang B. et al.

Olink Target 96CVDPathophysiologyPlasma

Neurotherapeutics, 2022
Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke

Simats A., Ramiro L., Valls R. et al.

Olink Target 96 MouseCVDNeurologyPathophysiologyTissue Lysate

Endocrine Connections, 2022
100 YEARS OF VITAMIN D: Combined hormonal contraceptives and vitamin D metabolism in adolescent girls

Öberg J., Jorde R., Figenschau Y. et al.

Olink Target 96EndocrinologyPathophysiologySerum

Frontiers in Cardiovascular Medicine, 2022
Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice

Kumawat A., Zegeye M., Paramel G. et al.

Olink Target 96 MouseCVDPathophysiologyPlasma

European Journal of Heart Failure, 2022
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial

Ferreira J., Verdonschot J., Girerd N. et al.

Olink Target 96CVDPatient StratificationPlasma

Atherosclerosis, 2022
Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort

Rastogi T., Girerd N., Lamiral Z. et al.

Olink Target 96Wider Proteomics StudiesCVDPathophysiologyPlasma

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022
CSF proteomic signature predicts progression to Alzheimer's disease dementia

Vromen E., del Campo Milán M., Scheltens P. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationCSF

International Journal of Molecular Sciences, 2022
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19

Costanzo M., Caterino M., Fedele R. et al.

Infectious DiseasesReview/editorial

British Journal of Dermatology, 2022
Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Navrazhina K., Frew J., Grand D. et al.

Olink Target 96Dermatological DiseasesPatient StratificationSerum

Brain, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity

Ruck T., Barman S., Schulte-Mecklenbeck A. et al.

Olink Explore 3072/384NeurologyPathophysiologySerumCSF

Inflammation, 2022
MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn´s Disease Patients

Gorreja F., Caër C., Rush S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Scientific Reports, 2022
Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)

Klimczak-Tomaniak D., de Bakker M., Bouwens E. et al.

Olink Target 96CVDPatient StratificationPlasma

Nature Communications, 2022
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

Al-Nesf M., Abdesselem H., Bensmail I. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma

Life, 2022
Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy

Johansson M., Ulfenborg B., Andersson C. et al.

Olink Target 96CVDPathophysiologyCell Culture Supernatant

Molecular Cancer, 2022
Proteomics technologies for cancer liquid biopsies

Ding Z., Wang N., Ji N. et al.

OncologyReview/editorial

3494 publications